| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ethanol binding | 1.70e-06 | 6 | 89 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.62e-04 | 24 | 89 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.07e-04 | 26 | 89 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.19e-04 | 30 | 89 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DDX19A ERCC6 ZCWPW2 DNAH10 ABCA6 SMCHD1 DNAH17 DDX25 KIF20B | 4.02e-04 | 614 | 89 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA helicase activity | 4.09e-04 | 78 | 89 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 4.50e-04 | 80 | 89 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | helicase activity | 7.08e-04 | 158 | 89 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.87e-04 | 441 | 89 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 9.93e-04 | 44 | 89 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.12e-03 | 102 | 89 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.48e-03 | 13 | 89 | 2 | GO:0046975 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 4.55e-05 | 47 | 88 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | B-WICH complex | 4.83e-04 | 8 | 88 | 2 | GO:0110016 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ANKRD13B RACK1 PTPRR SYNE1 SPTBN2 OSBPL1A OAS2 SNAP25 DAAM1 CYB5R4 KIF20B MAPK8IP3 | 5.31e-04 | 934 | 88 | 12 | GO:0048471 |
| GeneOntologyCellularComponent | SAGA-type complex | 5.90e-04 | 39 | 88 | 3 | GO:0070461 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 6.19e-04 | 9 | 88 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 6.19e-04 | 9 | 88 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 9.64e-04 | 269 | 88 | 6 | GO:0036464 | |
| Domain | ADH_Zn_CS | 5.19e-06 | 8 | 86 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 5.19e-06 | 8 | 86 | 3 | PS00059 | |
| Domain | Spectrin/alpha-actinin | 1.37e-05 | 32 | 86 | 4 | IPR018159 | |
| Domain | SPEC | 1.37e-05 | 32 | 86 | 4 | SM00150 | |
| Domain | CKAP2_C | 2.10e-05 | 2 | 86 | 2 | IPR029197 | |
| Domain | CKAP2_fam | 2.10e-05 | 2 | 86 | 2 | IPR026165 | |
| Domain | CKAP2_C | 2.10e-05 | 2 | 86 | 2 | PF15297 | |
| Domain | G-protein_beta_WD-40_rep | 4.52e-05 | 85 | 86 | 5 | IPR020472 | |
| Domain | ADH_N | 5.05e-05 | 16 | 86 | 3 | PF08240 | |
| Domain | PKS_ER | 5.05e-05 | 16 | 86 | 3 | SM00829 | |
| Domain | PKS_ER | 5.05e-05 | 16 | 86 | 3 | IPR020843 | |
| Domain | ADH_N | 5.05e-05 | 16 | 86 | 3 | IPR013154 | |
| Domain | - | 7.32e-05 | 18 | 86 | 3 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 8.66e-05 | 19 | 86 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 8.66e-05 | 19 | 86 | 3 | IPR002085 | |
| Domain | ADH_C | 8.66e-05 | 19 | 86 | 3 | IPR013149 | |
| Domain | Spectrin_bsu | 1.25e-04 | 4 | 86 | 2 | IPR016343 | |
| Domain | Actinin_actin-bd_CS | 1.56e-04 | 23 | 86 | 3 | IPR001589 | |
| Domain | Spectrin | 1.56e-04 | 23 | 86 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.56e-04 | 23 | 86 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.56e-04 | 23 | 86 | 3 | PS00019 | |
| Domain | GroES-like | 1.78e-04 | 24 | 86 | 3 | IPR011032 | |
| Domain | Spectrin_repeat | 3.16e-04 | 29 | 86 | 3 | IPR002017 | |
| Domain | Q_MOTIF | 6.54e-04 | 37 | 86 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 6.54e-04 | 37 | 86 | 3 | IPR014014 | |
| Domain | PH_dom-spectrin-type | 7.39e-04 | 9 | 86 | 2 | IPR001605 | |
| Domain | ARM-type_fold | 9.61e-04 | 339 | 86 | 7 | IPR016024 | |
| Domain | WD40_repeat_CS | 9.64e-04 | 164 | 86 | 5 | IPR019775 | |
| Domain | Helicase_C | 1.51e-03 | 107 | 86 | 4 | PF00271 | |
| Domain | HELICc | 1.51e-03 | 107 | 86 | 4 | SM00490 | |
| Domain | Helicase_C | 1.56e-03 | 108 | 86 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.61e-03 | 109 | 86 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.61e-03 | 109 | 86 | 4 | PS51192 | |
| Domain | DEXDc | 1.61e-03 | 109 | 86 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.67e-03 | 110 | 86 | 4 | IPR014001 | |
| Domain | PH | 1.79e-03 | 278 | 86 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 1.82e-03 | 279 | 86 | 6 | PS50003 | |
| Domain | PH_domain | 1.86e-03 | 280 | 86 | 6 | IPR001849 | |
| Domain | CS_dom | 2.41e-03 | 16 | 86 | 2 | IPR007052 | |
| Domain | CS | 2.41e-03 | 16 | 86 | 2 | PS51203 | |
| Domain | WD40_repeat_dom | 2.49e-03 | 297 | 86 | 6 | IPR017986 | |
| Domain | Ank_2 | 3.16e-03 | 215 | 86 | 5 | PF12796 | |
| Domain | CH | 3.35e-03 | 65 | 86 | 3 | SM00033 | |
| Domain | Ank | 4.05e-03 | 228 | 86 | 5 | PF00023 | |
| Domain | PH | 4.13e-03 | 229 | 86 | 5 | PF00169 | |
| Domain | CH | 4.13e-03 | 70 | 86 | 3 | PF00307 | |
| Domain | HEAT_REPEAT | 4.13e-03 | 70 | 86 | 3 | PS50077 | |
| Domain | - | 4.30e-03 | 71 | 86 | 3 | 1.10.418.10 | |
| Domain | - | 4.37e-03 | 333 | 86 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.50e-03 | 335 | 86 | 6 | IPR015943 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.65e-03 | 73 | 86 | 3 | IPR011545 | |
| Domain | CH | 4.65e-03 | 73 | 86 | 3 | PS50021 | |
| Domain | DEAD | 4.65e-03 | 73 | 86 | 3 | PF00270 | |
| Domain | CH-domain | 5.01e-03 | 75 | 86 | 3 | IPR001715 | |
| Domain | P-loop_NTPase | DDX19B DDX19A NLRP14 ERCC6 DNAH10 ABCA6 DDX25 MAGI3 KIF20B AGAP3 | 5.52e-03 | 848 | 86 | 10 | IPR027417 |
| Domain | - | 5.77e-03 | 248 | 86 | 5 | 1.25.40.20 | |
| Domain | ANK | 6.06e-03 | 251 | 86 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 6.27e-03 | 253 | 86 | 5 | PS50088 | |
| Domain | HSP20-like_chaperone | 6.34e-03 | 26 | 86 | 2 | IPR008978 | |
| Domain | Ankyrin_rpt-contain_dom | 6.37e-03 | 254 | 86 | 5 | IPR020683 | |
| Domain | ANK_REP_REGION | 6.37e-03 | 254 | 86 | 5 | PS50297 | |
| Domain | WD40 | 6.90e-03 | 259 | 86 | 5 | PF00400 | |
| Domain | Ankyrin_rpt | 7.24e-03 | 262 | 86 | 5 | IPR002110 | |
| Domain | ArfGap | 7.85e-03 | 29 | 86 | 2 | SM00105 | |
| Domain | ArfGap | 7.85e-03 | 29 | 86 | 2 | PF01412 | |
| Domain | ARFGAP | 7.85e-03 | 29 | 86 | 2 | PS50115 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 8.18e-06 | 10 | 59 | 3 | MM15833 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.12e-05 | 11 | 59 | 3 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.49e-05 | 12 | 59 | 3 | M14663 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 2.14e-05 | 136 | 59 | 6 | M42547 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 3.06e-05 | 15 | 59 | 3 | M39717 | |
| Pathway | WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME | 7.93e-05 | 106 | 59 | 5 | M40052 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.01e-04 | 22 | 59 | 3 | M27445 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.12e-04 | 28 | 59 | 3 | MM15188 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION | 3.47e-04 | 33 | 59 | 3 | M39909 | |
| Pathway | REACTOME_ABACAVIR_ADME | 4.74e-04 | 8 | 59 | 2 | MM14869 | |
| Pathway | WP_INSULIN_SIGNALING | 5.40e-04 | 160 | 59 | 5 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 5.40e-04 | 160 | 59 | 5 | M39482 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 7.12e-04 | 42 | 59 | 3 | M16743 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 7.12e-04 | 42 | 59 | 3 | M699 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 7.46e-04 | 98 | 59 | 4 | M48247 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 7.53e-04 | 261 | 59 | 6 | MM15676 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 7.58e-04 | 10 | 59 | 2 | MM15112 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 7.63e-04 | 43 | 59 | 3 | M27443 | |
| Pathway | WP_RETINOL_METABOLISM | 8.16e-04 | 44 | 59 | 3 | MM15851 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.12e-03 | 49 | 59 | 3 | MM15186 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 1.15e-03 | 110 | 59 | 4 | MM15977 | |
| Pubmed | 6.69e-08 | 4 | 90 | 3 | 12631290 | ||
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 11836246 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 1.67e-07 | 5 | 90 | 3 | 19193628 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 1.67e-07 | 5 | 90 | 3 | 22079585 | |
| Pubmed | SF3B1 RACK1 SEC62 SPTBN1 MINK1 CLTC XRN1 WDR5 SNAP25 DAAM1 KCNB2 SIPA1L2 MAP3K7 MAPK8IP3 AGAP3 | 2.25e-07 | 1139 | 90 | 15 | 36417873 | |
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 17257171 | ||
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 12027900 | ||
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 3.33e-07 | 6 | 90 | 3 | 16121213 | |
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 3.33e-07 | 6 | 90 | 3 | 9982 | |
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 518534 | ||
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 16047160 | ||
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 11784316 | ||
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 5.82e-07 | 7 | 90 | 3 | 23468174 | |
| Pubmed | NRDE2 SESTD1 PRAMEF33 PRAMEF10 RACK1 SETD5 PTPRR PIK3CD SPTBN1 CLTC ZBTB41 CKAP2 NCOA4 TTC3 | 7.50e-07 | 1084 | 90 | 14 | 11544199 | |
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 18331377 | ||
| Pubmed | 1.39e-06 | 9 | 90 | 3 | 11747070 | ||
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 1.66e-06 | 218 | 90 | 7 | 35831895 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SLC12A2 RACK1 SPTBN1 MINK1 SPTBN2 XRN1 MAGI3 SNAP25 DAAM1 FAM110C | 2.11e-06 | 565 | 90 | 10 | 25468996 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DDX19B MLXIPL SLC12A2 SPTBN1 MINK1 XRN1 GRB10 MAGI3 CKAP2 SIPA1L2 ARAP2 AGAP3 | 2.29e-06 | 861 | 90 | 12 | 36931259 |
| Pubmed | SP100 SF3B1 SETD5 SYNE1 SMCHD1 SEC62 SPTBN1 SPTBN2 CLTC XRN1 MAGI3 ZBTB41 SIPA1L2 TTC3 RPL3L | 4.21e-06 | 1442 | 90 | 15 | 35575683 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC6 RACK1 STRAP SMCHD1 EIF2B5 XRN1 CKAP2L WDR5 CKAP2 PAK1IP1 KIF20B | 4.33e-06 | 759 | 90 | 11 | 35915203 |
| Pubmed | SESTD1 SF3B1 SYNE1 SPTBN1 SPTBN2 CLTC OSBPL1A MAGI3 SNAP25 CKAP2 TTC3 DSCAML1 MAPK8IP3 AGAP3 | 5.41e-06 | 1285 | 90 | 14 | 35914814 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24594345 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11303599 | ||
| Pubmed | Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation. | 6.62e-06 | 2 | 90 | 2 | 33751071 | |
| Pubmed | SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes. | 6.62e-06 | 2 | 90 | 2 | 34930825 | |
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 6.62e-06 | 2 | 90 | 2 | 26884715 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30699353 | ||
| Pubmed | SESTD1 SF3B1 RACK1 STRAP SYNE1 SPTBN1 MINK1 SPTBN2 CLTC TTC3 MAPK8IP3 PROX1 | 7.16e-06 | 963 | 90 | 12 | 28671696 | |
| Pubmed | 7.55e-06 | 513 | 90 | 9 | 25798074 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.79e-06 | 281 | 90 | 7 | 28706196 | |
| Pubmed | 1.12e-05 | 408 | 90 | 8 | 33766124 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DDX19A MLXIPL STRAP EIF2B5 TMED8 XRN1 GRB10 WDR5 NCOA4 MAP3K7 IL33 SHQ1 | 1.51e-05 | 1038 | 90 | 12 | 26673895 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX19A SF3B1 RACK1 STRAP DNAH10 SYNE1 SMCHD1 SPTBN1 EIF2B5 CLTC WDR5 TAF5L PAK1IP1 TTC3 | 1.73e-05 | 1425 | 90 | 14 | 30948266 |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 1.98e-05 | 3 | 90 | 2 | 10424757 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11960985 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 2474823 | ||
| Pubmed | Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes. | 1.98e-05 | 3 | 90 | 2 | 20532808 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 1.98e-05 | 3 | 90 | 2 | 23772048 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 1.98e-05 | 3 | 90 | 2 | 24787690 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 2347582 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 3011597 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 6756216 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 1.98e-05 | 3 | 90 | 2 | 7748347 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 37806378 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 7840644 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 3006456 | ||
| Pubmed | RNA export factor Ddx19 is required for nuclear import of the SRF coactivator MKL1. | 1.98e-05 | 3 | 90 | 2 | 25585691 | |
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 1.98e-05 | 3 | 90 | 2 | 9145544 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 1.98e-05 | 3 | 90 | 2 | 6816803 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 26603638 | ||
| Pubmed | Alcohol dehydrogenase polymorphisms influence alcohol-elimination rates in a male Jewish population. | 1.98e-05 | 3 | 90 | 2 | 14745297 | |
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 1.98e-05 | 3 | 90 | 2 | 15670660 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 1.98e-05 | 3 | 90 | 2 | 15554233 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 35354963 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 6370228 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 1.98e-05 | 3 | 90 | 2 | 33586683 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 1.98e-05 | 3 | 90 | 2 | 3157987 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 2169444 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 1.98e-05 | 3 | 90 | 2 | 8486690 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 2935875 | ||
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 1.98e-05 | 3 | 90 | 2 | 16801720 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SP100 ERCC6 SF3B1 RACK1 STRAP SMCHD1 SPTBN1 SPTBN2 CLTC WDR5 CKAP2 PAK1IP1 KIF20B | 2.10e-05 | 1257 | 90 | 13 | 36526897 |
| Pubmed | 2.30e-05 | 130 | 90 | 5 | 12421765 | ||
| Pubmed | 2.49e-05 | 22 | 90 | 3 | 31729367 | ||
| Pubmed | 2.49e-05 | 22 | 90 | 3 | 10753524 | ||
| Pubmed | NRDE2 ERCC6 SLC12A2 RACK1 SETD5 SYNE1 MINK1 XRN1 TAF5L DAAM1 CKAP2 PAK1IP1 KIF20B AGAP3 | 2.98e-05 | 1497 | 90 | 14 | 31527615 | |
| Pubmed | SP100 ERCC6 RACK1 SETD5 TCP11L1 XRN1 TAF5L SIPA1L2 ARAP2 PROX1 AGAP3 ADH4 | 3.07e-05 | 1116 | 90 | 12 | 31753913 | |
| Pubmed | TDRD15 SF3B1 SLC12A2 RACK1 MINK1 CLTC XRN1 MAP3K7 ARAP2 AGAP3 | 3.34e-05 | 777 | 90 | 10 | 35844135 | |
| Pubmed | 3.70e-05 | 25 | 90 | 3 | 37451217 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 28453575 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 11893554 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 29663519 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 12851412 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 9733106 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 36224745 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 9202249 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 8813054 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 21412925 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 3.96e-05 | 4 | 90 | 2 | 3996732 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 9241435 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 10880953 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 2893758 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 9002638 | ||
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 3.96e-05 | 4 | 90 | 2 | 24064296 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 15193143 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 19687126 | ||
| Pubmed | 4.38e-05 | 494 | 90 | 8 | 26831064 | ||
| Pubmed | MLXIPL SF3B1 RACK1 STRAP SMCHD1 SPTBN1 CLTC CKAP2 MAP3K7 KIF20B | 4.69e-05 | 809 | 90 | 10 | 32129710 | |
| Pubmed | ANKRD36B NRDE2 SF3B1 RACK1 STRAP SMCHD1 SEC62 SPTBN1 SPTBN2 CLTC CKAP2L WDR5 PAK1IP1 | 5.13e-05 | 1371 | 90 | 13 | 36244648 | |
| Pubmed | 5.24e-05 | 28 | 90 | 3 | 25089626 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 8892527 | ||
| Interaction | DDX25 interactions | 4.28e-06 | 8 | 87 | 3 | int:DDX25 | |
| Interaction | ADH1B interactions | 2.15e-05 | 13 | 87 | 3 | int:ADH1B | |
| Interaction | HSP90B1 interactions | RACK1 DNAH10 PTPRR SEC62 SPTBN1 DNAH17 CLTC WDR5 DAAM1 SIPA1L2 MAP3K7 KIF20B | 2.23e-05 | 650 | 87 | 12 | int:HSP90B1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 5.39e-05 | 37 | 90 | 3 | chr4q23 | |
| Cytoband | 1p36.21 | 2.66e-04 | 63 | 90 | 3 | 1p36.21 | |
| Cytoband | 4q23 | 7.06e-04 | 20 | 90 | 2 | 4q23 | |
| GeneFamily | Alcohol dehydrogenases | 2.02e-06 | 8 | 61 | 3 | 397 | |
| GeneFamily | Ankyrin repeat domain containing | 1.62e-04 | 242 | 61 | 6 | 403 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.33e-04 | 7 | 61 | 2 | 1113 | |
| GeneFamily | DEAD-box helicases | 3.82e-04 | 42 | 61 | 3 | 499 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.48e-04 | 206 | 61 | 5 | 682 | |
| GeneFamily | Dyneins, axonemal | 1.47e-03 | 17 | 61 | 2 | 536 | |
| GeneFamily | WD repeat domain containing | 1.89e-03 | 262 | 61 | 5 | 362 | |
| GeneFamily | PRAME family | 2.95e-03 | 24 | 61 | 2 | 686 | |
| GeneFamily | Nucleoporins | 5.20e-03 | 32 | 61 | 2 | 1051 | |
| GeneFamily | ArfGAPs | 5.53e-03 | 33 | 61 | 2 | 395 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 7.23e-09 | 199 | 90 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.69e-07 | 200 | 90 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 2.02e-06 | 184 | 90 | 6 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 2.66e-06 | 193 | 90 | 6 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 2.66e-06 | 193 | 90 | 6 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 2.66e-06 | 193 | 90 | 6 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.66e-06 | 193 | 90 | 6 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.82e-06 | 195 | 90 | 6 | c6b5249ac8714b1b701cde31d00ab53f28355c36 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-06 | 198 | 90 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.27e-06 | 200 | 90 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.27e-06 | 200 | 90 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.27e-06 | 200 | 90 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.27e-06 | 200 | 90 | 6 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.27e-06 | 200 | 90 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 9.00e-06 | 138 | 90 | 5 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 162 | 90 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 165 | 90 | 5 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-05 | 168 | 90 | 5 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | Basal_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.46e-05 | 170 | 90 | 5 | 776d4224a682b6c648041827efd69794f88906f0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-05 | 171 | 90 | 5 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.53e-05 | 171 | 90 | 5 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-05 | 172 | 90 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.15e-05 | 179 | 90 | 5 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.41e-05 | 182 | 90 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.59e-05 | 184 | 90 | 5 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.98e-05 | 188 | 90 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 4.08e-05 | 189 | 90 | 5 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-05 | 190 | 90 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 4.29e-05 | 191 | 90 | 5 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 192 | 90 | 5 | 5692bd57093852d442400383850f416c497dcc7d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.40e-05 | 192 | 90 | 5 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.40e-05 | 192 | 90 | 5 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 4.62e-05 | 194 | 90 | 5 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.74e-05 | 195 | 90 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-05 | 196 | 90 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 4.85e-05 | 196 | 90 | 5 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.97e-05 | 197 | 90 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.09e-05 | 198 | 90 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.09e-05 | 198 | 90 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 198 | 90 | 5 | 24bc53bd8ef8f4f2f4fc377aeee75126ad5d311f | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 5.09e-05 | 198 | 90 | 5 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 5.09e-05 | 198 | 90 | 5 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 198 | 90 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 199 | 90 | 5 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 199 | 90 | 5 | 136f24597ddca5cf2175120975c94782a3232ec6 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-05 | 199 | 90 | 5 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 90 | 5 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | 008f137920cc3b599376706803c111d1d0ec17ef | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells-Neuroepithelial_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | 0e119c2742f2be19fde8890d1227bf277ead976f | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 90 | 5 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 1.53e-04 | 133 | 90 | 4 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-04 | 142 | 90 | 4 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.49e-04 | 151 | 90 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 151 | 90 | 4 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-04 | 154 | 90 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-04 | 154 | 90 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.82e-04 | 156 | 90 | 4 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.89e-04 | 157 | 90 | 4 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.96e-04 | 158 | 90 | 4 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-04 | 162 | 90 | 4 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 162 | 90 | 4 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.25e-04 | 162 | 90 | 4 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.25e-04 | 162 | 90 | 4 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.25e-04 | 162 | 90 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 164 | 90 | 4 | 29da0175bd3808a5b3039a6161c764105608ef96 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 164 | 90 | 4 | e83b632ac7e1dace946991ddfe1fbfbbffc3a88b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.41e-04 | 164 | 90 | 4 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-04 | 167 | 90 | 4 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 168 | 90 | 4 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-04 | 168 | 90 | 4 | 3fb79aaa858057c82645a90bd139fc4f096323c7 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 168 | 90 | 4 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 168 | 90 | 4 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 168 | 90 | 4 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-04 | 169 | 90 | 4 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-04 | 169 | 90 | 4 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.82e-04 | 169 | 90 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-04 | 170 | 90 | 4 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.99e-04 | 171 | 90 | 4 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.99e-04 | 171 | 90 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.01e-04 | 71 | 90 | 3 | 2220e1b02baa71961cfc85536bafeb313e588bf3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.01e-04 | 71 | 90 | 3 | cc5de8bbcfefa2bf93cc137c74b49a745d5da229 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.08e-04 | 172 | 90 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 172 | 90 | 4 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 172 | 90 | 4 | 29c8510f26527d487d0fc3543102d067cdb281a6 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.08e-04 | 172 | 90 | 4 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 172 | 90 | 4 | 714172f31abd0d25261df6115ec6a9df491fa14b | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 173 | 90 | 4 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| Computational | Genes in the cancer module 514. | 1.74e-05 | 10 | 58 | 3 | MODULE_514 | |
| Computational | Oxidoreductases. | 2.13e-04 | 22 | 58 | 3 | MODULE_373 | |
| Drug | N-heptylformamide | 3.08e-06 | 8 | 88 | 3 | CID000347402 | |
| Drug | 2-NA | 4.61e-06 | 9 | 88 | 3 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 4.61e-06 | 9 | 88 | 3 | CID000440672 | |
| Drug | AC1L1J0I | 1.20e-05 | 12 | 88 | 3 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 1.20e-05 | 12 | 88 | 3 | CID000008104 | |
| Drug | Ethylene Glycols | 1.48e-05 | 2 | 88 | 2 | ctd:D005026 | |
| Drug | Cyclohexylformamide | 1.48e-05 | 2 | 88 | 2 | DB03559 | |
| Drug | 2-naphthaldehyde | 1.55e-05 | 13 | 88 | 3 | CID000006201 | |
| Drug | naphthalenemethanol | 1.97e-05 | 14 | 88 | 3 | CID000020908 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 2.45e-05 | 15 | 88 | 3 | CID000440673 | |
| Drug | phenoxyethanol | 3.01e-05 | 16 | 88 | 3 | CID000031236 | |
| Drug | naphthaldehyde | 3.01e-05 | 16 | 88 | 3 | CID000006195 | |
| Drug | 6-propionyl-2-(dimethylamino)naphthalene | 3.01e-05 | 16 | 88 | 3 | CID000107729 | |
| Drug | 4-Iodopyrazole | 4.42e-05 | 3 | 88 | 2 | DB02721 | |
| Drug | BMS-214662 | 4.90e-05 | 52 | 88 | 4 | CID000448545 | |
| Drug | C x F | 5.17e-05 | 19 | 88 | 3 | CID000013017 | |
| Drug | lariat | 5.48e-05 | 105 | 88 | 5 | CID000165706 | |
| Drug | Ethylene Glycol | 7.06e-05 | 21 | 88 | 3 | ctd:D019855 | |
| Disease | fish oil supplement exposure measurement, low density lipoprotein cholesterol measurement | 4.90e-05 | 4 | 85 | 2 | EFO_0004611, EFO_0600007 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 4.90e-05 | 4 | 85 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | IGF-1 measurement | 8.35e-05 | 488 | 85 | 8 | EFO_0004627 | |
| Disease | cerebrospinal fluid clusterin measurement | 1.41e-04 | 35 | 85 | 3 | EFO_0007657 | |
| Disease | Colorectal Carcinoma | 1.91e-04 | 702 | 85 | 9 | C0009402 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.47e-04 | 303 | 85 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 2.89e-04 | 312 | 85 | 6 | EFO_0004612, EFO_0010351 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.00e-04 | 45 | 85 | 3 | EFO_0022236 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 3.04e-04 | 315 | 85 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | lipoprotein A measurement | 3.14e-04 | 112 | 85 | 4 | EFO_0006925 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.86e-04 | 49 | 85 | 3 | EFO_0022256 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 4.35e-04 | 51 | 85 | 3 | EFO_0022242 | |
| Disease | tuberculosis (is_marker_for) | 4.44e-04 | 11 | 85 | 2 | DOID:399 (is_marker_for) | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 4.87e-04 | 53 | 85 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 4.87e-04 | 53 | 85 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 5.15e-04 | 54 | 85 | 3 | EFO_0022244 | |
| Disease | beta wave measurement | 5.31e-04 | 12 | 85 | 2 | EFO_0006871 | |
| Disease | triglycerides in medium VLDL measurement | 5.43e-04 | 55 | 85 | 3 | EFO_0022155 | |
| Disease | alcohol dependence measurement | 5.43e-04 | 55 | 85 | 3 | EFO_0007835 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 5.73e-04 | 56 | 85 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 5.73e-04 | 56 | 85 | 3 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 6.03e-04 | 57 | 85 | 3 | EFO_0022284 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 6.35e-04 | 58 | 85 | 3 | EFO_0022338 | |
| Disease | cholesterol in IDL measurement | 6.35e-04 | 58 | 85 | 3 | EFO_0021899 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 6.68e-04 | 59 | 85 | 3 | EFO_0022289 | |
| Disease | triglycerides in small VLDL measurement | 7.36e-04 | 61 | 85 | 3 | EFO_0022145 | |
| Disease | free cholesterol in IDL measurement | 7.36e-04 | 61 | 85 | 3 | EFO_0022181 | |
| Disease | free cholesterol in very large VLDL measurement | 7.36e-04 | 61 | 85 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 7.72e-04 | 62 | 85 | 3 | EFO_0022169 | |
| Disease | phospholipids in very large VLDL measurement | 7.72e-04 | 62 | 85 | 3 | EFO_0022299 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 8.09e-04 | 63 | 85 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 8.09e-04 | 63 | 85 | 3 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 8.47e-04 | 64 | 85 | 3 | EFO_0022253 | |
| Disease | alcohol consumption measurement | MLXIPL SPTBN1 XRN1 MAGI3 ZSWIM2 MAP3K7 ARAP2 TANGO6 ADH1A ADH1C ADH4 | 8.64e-04 | 1242 | 85 | 11 | EFO_0007878 |
| Disease | cholesterol in large VLDL measurement | 8.86e-04 | 65 | 85 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 8.86e-04 | 65 | 85 | 3 | EFO_0022230 | |
| Disease | very low density lipoprotein cholesterol measurement | 9.44e-04 | 260 | 85 | 5 | EFO_0008317 | |
| Disease | total lipids in small VLDL | 9.67e-04 | 67 | 85 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 9.67e-04 | 67 | 85 | 3 | EFO_0022175 | |
| Disease | hearing loss | 9.67e-04 | 67 | 85 | 3 | EFO_0004238 | |
| Disease | free cholesterol in large VLDL measurement | 1.01e-03 | 68 | 85 | 3 | EFO_0022265 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.02e-03 | 153 | 85 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | brain measurement, neuroimaging measurement | 1.06e-03 | 550 | 85 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | Alcoholic Intoxication, Chronic | 1.08e-03 | 268 | 85 | 5 | C0001973 | |
| Disease | unipolar depression, alcohol dependence | 1.50e-03 | 78 | 85 | 3 | EFO_0003761, MONDO_0007079 | |
| Disease | colorectal carcinoma (is_implicated_in) | 1.82e-03 | 22 | 85 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | blood pressure | 1.82e-03 | 22 | 85 | 2 | EFO_0004325 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.92e-03 | 85 | 85 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.96e-03 | 307 | 85 | 5 | EFO_0004612, EFO_0020946 | |
| Disease | Carcinoma of lung | 1.99e-03 | 23 | 85 | 2 | C0684249 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 2.17e-03 | 24 | 85 | 2 | EFO_0009458, MONDO_0007079 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.19e-03 | 315 | 85 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | lipid measurement, lipoprotein measurement | 2.26e-03 | 90 | 85 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | C-reactive protein measurement | TDRD15 MLXIPL SFRP2 ABCA6 SETD5 DNAH17 SETD4 KCNB2 MAPK8IP3 ADH1C | 2.43e-03 | 1206 | 85 | 10 | EFO_0004458 |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.68e-03 | 330 | 85 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.70e-03 | 200 | 85 | 4 | EFO_0004611, EFO_0020945 | |
| Disease | Agouti-related protein measurement | 2.75e-03 | 27 | 85 | 2 | EFO_0008016 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVWKKCSLNKTGKFA | 211 | A0A0G2JMD5 | |
| SLNKEWKKKYVTLCD | 381 | Q96P47 | |
| KVIKCKAAVLWELKK | 6 | P07327 | |
| KVIKCKAAIAWEAGK | 6 | P08319 | |
| KVIKCKAAVLWELKK | 6 | P00326 | |
| QTKALLCKNFLKKWR | 11 | Q8N139 | |
| SEKKLLEETNKKWCV | 911 | Q8WZ64 | |
| KNTFCLWKRLIKLKD | 811 | Q8N2N9 | |
| DDKCNLAKFWICKKS | 366 | Q9NNX6 | |
| VLDWCFKLKLIDLTK | 226 | Q9UHL0 | |
| DAKKLVKYWICLALI | 456 | Q8WWK9 | |
| KQRKKKAWIYCESLS | 136 | Q8NBR0 | |
| DKLVKVWNLANCKLK | 171 | P63244 | |
| KCKWLKKWIKKCDDD | 316 | Q9Y4X5 | |
| LTTKTQKFKAKLWLC | 361 | Q86YJ7 | |
| TKILCKWKKADLTVQ | 576 | P0DP91 | |
| DKIDKWDLIKLKSFC | 1006 | O00370 | |
| KKKKHWLSKVQECAV | 6 | Q5TCQ9 | |
| VANWKKCLHSIKLKD | 986 | Q9UPT6 | |
| CWKAAQIKEHLLKSK | 96 | Q13144 | |
| WEECKEIVKASSKKS | 1061 | Q96Q89 | |
| CKAKWRAKDVAIKQI | 51 | O43318 | |
| VDLKLAKLKLCTEFW | 381 | Q9H7Z3 | |
| TGDKLKFCLFTKWLK | 101 | P29728 | |
| QDKSKKKLCALYGKW | 761 | Q9BXW6 | |
| ITKLKEKNEKCVLYW | 491 | Q15256 | |
| NCEKEALYKWLLKKE | 421 | Q13772 | |
| DLWEFFCRKKAQLKK | 176 | Q9NR21 | |
| ALPAEKKWQIYCSKK | 76 | Q9Y4D1 | |
| KWKNTASKALCFKLG | 16 | O95760 | |
| CCPDKRKKLWDLLEK | 171 | Q92953 | |
| LKHWFDCLKNKDKRI | 381 | Q14184 | |
| NLKTKEKAAKWILAA | 4441 | Q9UFH2 | |
| KLDSLKCGTWYKVKL | 1441 | Q8TD84 | |
| KCGTWYKVKLAAKNS | 1446 | Q8TD84 | |
| VLDWCSKLKFIDPKK | 221 | Q9UMR2 | |
| ELGKKSWKKLYVCLR | 301 | Q13322 | |
| WLNGKEYKCKVSNKA | 196 | P01857 | |
| LDWCSKLKFIDPKKI | 221 | Q9NUU7 | |
| KNKKWKKQDLCLGST | 536 | Q6UWX4 | |
| SLEKSKRKKPCAWLS | 3756 | Q8IVF4 | |
| ARIIKWLYTCKKAKE | 291 | Q1W6H9 | |
| WVKQRKDLLHLCCKK | 76 | H0Y7S4 | |
| KKWSKKFIDFIDTCL | 256 | Q8N4C8 | |
| LKKELTEEWQKACAK | 391 | Q4G0U5 | |
| CIKLWSLRSKKLKSE | 291 | O75529 | |
| KKRVKEIVHKAFWDC | 101 | Q9NUJ3 | |
| WLACEDFKKTKNADK | 51 | Q2M5E4 | |
| DLKKSVLWLKDSLQC | 231 | Q96HF1 | |
| LWLKDCHEKYDKQIK | 561 | A6NHR9 | |
| CWLKDKAKQIAQKDV | 2036 | Q8NF91 | |
| KKLAFLLKDWEKCEK | 7666 | Q8NF91 | |
| CVINELLKWKACSKL | 1461 | B5MCY1 | |
| LLKWKACSKLQKSAL | 1466 | B5MCY1 | |
| DWHKSKKKAFTKACK | 121 | Q92901 | |
| KNACKLKAILSKWLE | 181 | P28069 | |
| WKKAIYKVICKLDSE | 706 | Q92786 | |
| KKDCSKELTCKALWE | 86 | Q9P2F8 | |
| KLLCLEAEKFTCWKK | 346 | Q9NVD3 | |
| CKDNADLLSPLKKWK | 821 | Q9C0A6 | |
| YCVWIQKVKSKKLAA | 386 | Q6PI26 | |
| EKKFLWKALGTTLAC | 611 | Q7Z745 | |
| ELKKHNKKDDCWICI | 61 | Q7L1T6 | |
| WKNFKGLKLLCRDKI | 106 | Q9NP71 | |
| IKKALWCSEDKQILS | 146 | Q9Y3F4 | |
| PCNKLKSSDAYKKAW | 91 | P60880 | |
| KKVTHFCFWKEKDRL | 106 | Q86VW0 | |
| EKKSAKDALLLWCQM | 171 | Q01082 | |
| WKQSVELCKKDSLYK | 1521 | Q00610 | |
| AEKFAKFWICKAKLL | 551 | Q8IYA6 | |
| KFWICKAKLLASKGT | 556 | Q8IYA6 | |
| SVALKKKAKCLLSKW | 61 | Q8N8B7 | |
| KKAKCLLSKWKAVYK | 66 | Q8N8B7 | |
| KAVDCLLDSKWAKAK | 51 | Q99442 | |
| KSAKDALLLWCQMKT | 176 | O15020 | |
| PFLKAVCKSKKSWQA | 646 | O75533 | |
| KKTKSESWKCDICKK | 456 | Q5SVQ8 | |
| YLLTTKKKWKDCKIR | 1041 | P55011 | |
| LKKCSETWKTIFAKE | 716 | P23497 | |
| EKKKLKGQENSLCWT | 386 | Q8IZH2 | |
| DWKKCDLIAKILASC | 346 | Q9C0B7 | |
| CWKKLKTTTFNDKID | 691 | P53804 | |
| STKKKSKKADCPIAW | 406 | O00329 | |
| EVWKKCSLNKTGKFA | 211 | O60809 | |
| KKWECLKSIKAHKGQ | 111 | Q9NWT1 | |
| GLKSFSWKKLQCLKN | 686 | Q9NYK1 | |
| CKRKNILEWAKELSL | 201 | P57060 | |
| KFLAACAAGKWILTK | 56 | Q9BQI6 | |
| CKHICWVLLKKFKLP | 76 | Q8NEG5 | |
| DKQKWCDVCKKLVDL | 111 | Q6PGP7 | |
| KKKWYKSALQEACLL | 171 | Q504Y3 | |
| WCTKSILKYICKKQK | 21 | Q9NWC5 | |
| NTLKLWDYSKGKCLK | 236 | P61964 | |
| KCKTHCLATKKLDLW | 1056 | P35125 | |
| CIWTFAKVKEFKSKL | 161 | Q6PL24 | |
| KEKFCITWDKKSLAG | 131 | Q86W24 | |
| WDAKSRGILKCKKDK | 231 | Q9NR99 |